Medical Policy Reference Manual

00. Introduction
01. Durable Medical Equipment
02. Medicine
03. Mental Health
04. OB/GYN/Reproduction
05. Prescription Drug
06. Radiology/Imaging
07. Surgery
08. Rehabilitation Therapy
09. Anesthesia
10. Administrative
11. Laboratory/Pathology
	11.01.001		Tumor Markers
	11.01.002		Genetic Testing for Inherited BRCA1 or BRCA2 Mutations
	11.01.004		Genetic Testing and Biochemical Markers for the Diagnosis of Alzheimer's Disease
	11.01.005		Cathepsin-D
	11.01.007		Genetic Testing for Germline Mutations of the RET Proto-Oncogene in Medullary Carcinoma of the Thyroid
	11.01.008		Salivary Melatonin Profile
	11.01.009		Hypo-osmotic Swelling Test for Sperm Function
	11.01.015		Preconception Sex Selection Techniques
	11.01.019		In Vitro Chemotherapeutic Drug Assays
	11.01.020		Salivary Estriol for Assessment of Risk for Preterm Labor
	11.01.025		Genetic Testing for Cystic Fibrosis
	11.01.026		Testing for Tay-Sachs Disease
	11.01.027		Genetic Testing for Canavan Disease
	11.01.028		Serum Proteomic Pattern Analysis Testing for Screening or Diagnosis of Ovarian Cancer
	11.01.029		Serum Antibody Marker Testing for Inflammatory Bowel Disease
	11.01.030A		Speculoscopy for Cervical Cancer Screening
	11.01.031		Pharmacogenomic and Serologic Metabolite Markers for Inflammatory Bowel Disease Patients Treated with Azathioprine
	11.01.032		Assays of Genetic Expression in Tumor Tissue to Determine Prognosis in Breast Cancer Patients
	11.01.033		Cytochrome P450 Genotyping
	11.01.034		Molecular Genetic Expression Test for Identification of Heart Transplant Rejection
	11.01.035		Genetic Testing for Celiac Disease
	11.01.036		Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)
	11.01.037		Serum Biomarker Panels for Assessment of Hepatic Fibrosis
	11.01.038		Pharmacogenomic Testing for Warfarin Sensitivity
	11.01.039		Genetic Testing for Cardiac Ion Channel Mutations
	11.01.040		Topographic Genotyping, Quantitative Mutational Analysis, e.g. PathfinderTG®
	11.01.041		KRAS Mutation Analysis in Metastatic Colorectal Cancer
	11.01.042		MicroRNA Analysis for Cancer of Unknown Primary Origin
	11.01.043		Systems Pathology for Prediction of Recurrence of Prostate Cancer
99. Archived...01. Durable Medical Equipment
99. Archived...02. Medicine
99. Archived...04. OB/GYN/Reproduction
99. Archived...05. Prescription Drug
99. Archived...06. Radiology/Imaging
99. Archived...07. Surgery
99. Archived...08. Rehabilitation Therapy
99. Archived...11. Laboratory/Pathology

Request Search